Investments opportunities can come up at any time, so investors need to be well prepared to make the most of these opportunities, you definitely donât want to miss out on these quality stocks and in the current market where volatility still persists investors are a little choosy, lets take a look at few of the most discussed stocks:
TNG LIMITED (ASX:TNG) â Key highlights of the updated feasibility study included a 12% reduction in pre-production CAPEX to A$853 million, a pre-tax NPV8% of A$4.7 billion, forecast life-of-mine net cash-flow of A$11.7 billion and a reduced capital payback period of three years. Joining the companyâs share register, $3.911M capital raising completed with a number of leading Australian institutional investors. At financial year end, the company had cash reserves of $5.73 million which represents health balance sheet with no debt. The stock is trading near its 52-week low which went up 9.524% at $ 0.115 as at October 30, 2018. However, the stock has witnessed a performance change of 160.50% over the past 60 months.
BIOTRON LIMITED (ASX:BIT) â After the company announced positive clinical trials results of its lead drug BIT225, Biotronâs share price has jumped. The financial performance is yet to be improved as the group is yet to report significant revenue while the FY18 net loss has been down 48.5% $1,593,645 compared to 2017 loss of $3,093,405 and in view of which the directors recommend that no dividend be paid by the company. There has been recently reported positive news from the HIV-1 Phase 2 trial. The company secured $4.7 million underwriting agreement for 30 Nov â18 for $0.06 options. The stock is trading 3.03% higher at $ 0.170 as at October 30, 2018. However, the stock has witnessed a performance change of a staggering 549.64% over the past 12 months.Â
FLUENCE CORPORATION LIMITED (ASX:FLC) â The company raised A$33.1 million via placement of ordinary shares to domestic and global sophisticated, professional and other institutional investors to underpin growth plans. The Group has confirmed its full year guidance and revenue from Q1 2018 has doubled in Q2 2018. The company reported a revenue which was up 28% on Q2 2018 of US$29.0 million. First EBITDA-positive quarter reflects higher Q3 revenues with US$0.5 million and further cost efficiencies being realized. Net cash used was US$12.9 million from operating activities in Q3 2018, while cash reserves at 30 September 2018 were US$23.1 million. The stock declined by -15.385%, as at October 30, 2018, to trade at a market price of $0.385. The stock witnessed a performance change of 12.35% over the past 6 months.
CELSIUS RESOURCES LIMITED (ASX:CLA) â The principal activities of the consolidated entity consisted of mineral exploration and mineral extraction via joint venture arrangements. The loss of the consolidated entity amounted to $2,790,788 as compared to 2017 loss of $781,822 after providing for income tax and eliminating non-controlling equity interests. No dividends were paid or declared since the start of the financial year, no dividend has been recommended. The consolidated entityâs net working capital, being current assets minus current liabilities is a net current asset of $13,382,201 compared to 2017 of $3,826,418 which represents the ability to pay short term loan obligations. The stock traded flat at a market price of $0.105 as at October 30, 2018 and has a market capitalization of $75.71 million.
GALAXY RESOURCES LIMITED (ASX:GXY) â From the previous comparable period, the company reported decent half-year financial performance with profit after tax growing tremendously. Primarily due to higher unit costs of production arising from lower production, Mt Cattlin reported an average cash margin per dmt sold of US$411 for the quarter, a reduction from the previous quarter. The group has enough cash resources as at 30 June 2018, the group had cash and cash equivalent of $ 45.12 Mn with zero debt to take care of the funding requirements for the ongoing projects and optimization initiatives. In terms of its shares held short number of short positions reported attributed to 20.05%. As at October 30, 2018, the stock was up by 5.164%, to trade at a market price of $2.240 near its 52-week low. In the twelve months the stock has seen a performance change of -38.44%.
Disclaimer
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.
Â